Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scapuloperoneal neuropathy: a distinct clinicopathologic entity.

C L Hyser1, J T Kissel, J R Warmolts

  • 1Department of Neurology, Ohio State University Hospital, Columbus 43210.

Journal of the Neurological Sciences
|October 1, 1988
PubMed
Summary

Scapuloperoneal neuropathy, a distinct condition, is supported by evidence from three men with progressive muscle weakness and sensory loss. Diagnostic studies revealed primary axonal damage with secondary nerve repair.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice.

Gene therapy·2015
Same author

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

Gene therapy·2015
Same author

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis.

Neuromuscular disorders : NMD·2013
Same author

Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.

Molecular therapy : the journal of the American Society of Gene Therapy·2013
Same author

A simplified inlay technique.

Dental digest·2010
Same author

Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach.

Neurology·2010

Area of Science:

  • Neurology
  • Neuroscience
  • Peripheral Nervous System Disorders

Background:

  • The classification of scapuloperoneal syndrome remains debated, particularly regarding the role of peripheral neuropathy.
  • Establishing distinct nosologic entities is crucial for accurate diagnosis and treatment.

Observation:

  • Three male patients presented with a slowly progressive disorder over 5-17 years.
  • Key clinical features included significant weakness and atrophy in scapular stabilizers, shoulder girdle, and distal lower extremity muscles.
  • Patients also exhibited distal pan-modality sensory loss affecting multiple sensory pathways.

Findings:

  • Electrodiagnostic studies indicated a primary axonal neuropathy.
  • Sural nerve biopsies confirmed axonal damage with evidence of secondary demyelination and remyelination, suggesting a regenerative process.

Related Experiment Videos

Implications:

  • This study provides further evidence supporting scapuloperoneal neuropathy as a separate nosologic entity.
  • Understanding this specific neuropathy can improve diagnostic accuracy for patients with scapuloperoneal symptoms.
  • Further research into the pathogenesis and treatment of this condition is warranted.